Structure Therapeutics stock jumped about 6% in overnight trading as its CEO expects oral weight-loss pills to capture as much as half of the GLP-1 market by 2030, driven partly by pent-up demand from patients and doctors.

Structure estimates a market of between one and three billion obese and overweight people worldwide for oral weight-loss drugs, CEO Raymond Stevens told Reuters on Wednesday.

Springview Holdings Ltd. stock rose another 16% in overnight trading after unveiling a new clean-energy initiative tied to its Singapore housing business. Shares gained as much as 674% on Thursday. The sharp move reflects heightened investor appetite for small-cap names linked to renewable energy and sustainability themes.

WeRide stock rose about 5% in overnight trading. WeRide's robotaxi fleet size will likely grow to 2,000 to 3,000 by the end of this year, with the domestic market accounting for about 50%-60% of the increase, Citi analysts write in a note. Its overseas robotaxi fleet could reach 500 to 1,000 at the end of 2026, including more than 300 vehicles in Abu Dhabi, they add.

Hesai Group gained another 3%. Shares of Chinese lidar maker Hesai Group could see further upside as the adoption of higher-level autonomous driving systems accelerates in China, Bank of America analysts said in a research note.

BofA said the development of Level 3 advanced driver assistance systems (ADAS) is expected to significantly increase lidar penetration per vehicle, supporting strong volume growth and higher long-term content value for suppliers.